Author:
FitzGerald J. Mark,O’Byrne Paul M.,Bateman Eric D.,Barnes Peter J.,Zheng Jinping,Ivanov Stefan,Lamarca Rosa,Larsdotter Ulrika,Emerath Ulrika,Jansen Gerreke,Puu Margareta,Alagappan Vijay K. T.,Surmont Filip,Reddel Helen K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference33 articles.
1. Global Initiative for Asthma. 2020 GINA Report, Global Strategy for Asthma Management and Prevention. 2020. www.ginasthma.org/reports. Accessed 16 Apr 2020
2. British Thoracic Society and Scottish Intercollegiate Guidelines Network. SIGN 158 British guideline on the management of asthma. 2019. https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/. Accessed 16 Apr 2020
3. Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, et al. Association of inhaled corticosteroids and long-acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319(14):1485–96.
4. Atienza T, Aquino T, Fernandez M, Boonsawat W, Kawai M, Kudo T, et al. Budesonide/formoterol maintenance and reliever therapy via turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results. Respirology. 2013;18(2):354–63.
5. Bateman ED, Reddel HK, O’Byrne P, Barnes PJ, Zhong N, Keen C, et al. As-needed budesonide–formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–87.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献